Literature DB >> 22670581

Obesity and hypertension in cardiac hypertrophy: two sides of the same coin?

Riccardo Sarzani, Federico Guerra.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22670581     DOI： 10.2165/11632080-000000000-00000

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN： 1120-9879


× No keyword cloud information.
  5 in total

1.  Prevalence of left ventricular hypertrophy and determinants of left ventricular mass in obese women.

Authors:  Guido Salvetti; Andrea Pucci; Paola Fierabracci; Giovanni Ceccarini; Caterina Palagi; Maria Grazia Delle Donne; Vitantonio Di Bello; Paolo Piaggi; Paolo Vitti; Antonio Salvetti; Aldo Pinchera; Ferruccio Santini
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-03-01

2.  Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women.

Authors:  Giuseppe Schillaci; Matteo Pirro; Giacomo Pucci; Massimo R Mannarino; Fabio Gemelli; Donatella Siepi; Gaetano Vaudo; Elmo Mannarino
Journal:  Hypertension       Date:  2006-04-03       Impact factor: 10.190

3.  Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults.

Authors:  G de Simone; R B Devereux; M J Roman; M H Alderman; J H Laragh
Journal:  Hypertension       Date:  1994-05       Impact factor: 10.190

4.  Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk.

Authors:  G de Simone; R B Devereux; S R Daniels; M J Koren; R A Meyer; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

5.  The association of left ventricular hypertrophy with metabolic syndrome is dependent on body mass index in hypertensive overweight or obese patients.

Authors:  Federico Guerra; Lucia Mancinelli; Luca Angelini; Marco Fortunati; Alessandro Rappelli; Paolo Dessì-Fulgheri; Riccardo Sarzani
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.